Huang, P., Li, Z., Zhang, K., Wang, M., Kang, Z., Su, Y., Wei, W., Zhang, Y., Song, Y., Zhao, X. (2025). FOLFOX-HAIC/TACE combined with lenvatinib plus tislelizumab as a conversion therapy in initial unresectable hepatocellular carcinoma: A retrospective real-world study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16201